カテゴリー： LP Information, 世界, 部品/材料

世界のアブロシチニブAPI市場予測 2023年-2029年

◆英語タイトル：Global Abrocitinib API Market Growth 2023-2029
	◆商品コード：LP23JU0436 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：100 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアブロシチニブAPI市場」は、過去の販売実績から2022年の世界のアブロシチニブAPIの総販売量を検討し、2023年から2029年の予測されるアブロシチニブAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアブロシチニブAPIの市場規模を掲載し、XXX百万米ドル規模の世界のアブロシチニブAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のアブロシチニブAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアブロシチニブAPI市場における各社の独自のポジションをより深く理解するために、アブロシチニブAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアブロシチニブAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アブロシチニブAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アブロシチニブAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アブロシチニブAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アブロシチニブAPIの世界主要メーカーとしては、Toronto Research Chemicals、 AbMole BioScience、 TargetMol Chemicals、 Pfizer、 CSNpharm、 Abcam、 Cayman Chemical、 MedKoo Biosciences、 Clearsynth、 Changzhou Pharmaceutical Factory、 ComWin Internationaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアブロシチニブAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアブロシチニブAPI市場をセグメンテーションし、種類別 (純度98%以上、純度99%以上)、用途別 (研究機関、製薬、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以上、純度99%以上

・用途別区分：研究機関、製薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアブロシチニブAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たアブロシチニブAPI市場成長の要因は何か？
・アブロシチニブAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・アブロシチニブAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アブロシチニブAPIの年間販売量2018-2029、地域別現状・将来分析
・アブロシチニブAPIの種類別セグメント：純度98%以上、純度99%以上
・アブロシチニブAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アブロシチニブAPIの用途別セグメント：研究機関、製薬、その他
・アブロシチニブAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアブロシチニブAPI市場
・企業別のグローバルアブロシチニブAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアブロシチニブAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のアブロシチニブAPI販売価格
・主要企業のアブロシチニブAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アブロシチニブAPIの地域別レビュー
・地域別のアブロシチニブAPI市場規模2018-2023：年間販売量、売上
・主要国別のアブロシチニブAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのアブロシチニブAPI販売の成長
・アジア太平洋のアブロシチニブAPI販売の成長
・ヨーロッパのアブロシチニブAPI販売の成長
・中東・アフリカのアブロシチニブAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のアブロシチニブAPI販売量、売上（2018-2023）
・南北アメリカのアブロシチニブAPIの種類別販売量
・南北アメリカのアブロシチニブAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアブロシチニブAPI販売量、売上（2018-2023）
・アジア太平洋のアブロシチニブAPIの種類別販売量
・アジア太平洋のアブロシチニブAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアブロシチニブAPI販売量、売上（2018-2023）
・ヨーロッパのアブロシチニブAPIの種類別販売量
・ヨーロッパのアブロシチニブAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアブロシチニブAPI販売量、売上（2018-2023）
・中東・アフリカのアブロシチニブAPIの種類別販売量
・中東・アフリカのアブロシチニブAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アブロシチニブAPIの製造コスト構造分析
・アブロシチニブAPIの製造プロセス分析
・アブロシチニブAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アブロシチニブAPIの主要なグローバル販売業者
・アブロシチニブAPIの主要なグローバル顧客

地域別のアブロシチニブAPI市場予測レビュー
・地域別のアブロシチニブAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アブロシチニブAPIの種類別市場規模予測
・アブロシチニブAPIの用途別市場規模予測

主要企業分析
Toronto Research Chemicals、 AbMole BioScience、 TargetMol Chemicals、 Pfizer、 CSNpharm、 Abcam、 Cayman Chemical、 MedKoo Biosciences、 Clearsynth、 Changzhou Pharmaceutical Factory、 ComWin Internationa
・企業情報
・アブロシチニブAPI製品
・アブロシチニブAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Abrocitinib is an oral, small molecule, Janus kinase (JAK) 1 inhibitor in development for the treatment of adults and adolescents with moderate to severe atopic dermatitis.
LPI (LP Information)’ newest research report, the “Abrocitinib API Industry Forecast” looks at past sales and reviews total world Abrocitinib API sales in 2022, providing a comprehensive analysis by region and market sector of projected Abrocitinib API sales for 2023 through 2029. With Abrocitinib API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Abrocitinib API industry.
This Insight Report provides a comprehensive analysis of the global Abrocitinib API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Abrocitinib API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Abrocitinib API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Abrocitinib API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Abrocitinib API.
The global Abrocitinib API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Abrocitinib API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Abrocitinib API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Abrocitinib API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Abrocitinib API players cover Toronto Research Chemicals, AbMole BioScience, TargetMol Chemicals, Pfizer, CSNpharm, Abcam, Cayman Chemical, MedKoo Biosciences and Clearsynth, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Abrocitinib API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Toronto Research Chemicals
AbMole BioScience
TargetMol Chemicals
Pfizer
CSNpharm
Abcam
Cayman Chemical
MedKoo Biosciences
Clearsynth
Changzhou Pharmaceutical Factory
ComWin Internationa
Key Questions Addressed in this Report
What is the 10-year outlook for the global Abrocitinib API market?
What factors are driving Abrocitinib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Abrocitinib API market opportunities vary by end market size?
How does Abrocitinib API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Abrocitinib API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Abrocitinib API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Abrocitinib API by Country/Region, 2018, 2022 & 2029
2.2 Abrocitinib API Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Abrocitinib API Sales by Type
2.3.1 Global Abrocitinib API Sales Market Share by Type (2018-2023)
2.3.2 Global Abrocitinib API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Abrocitinib API Sale Price by Type (2018-2023)
2.4 Abrocitinib API Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Abrocitinib API Sales by Application
2.5.1 Global Abrocitinib API Sale Market Share by Application (2018-2023)
2.5.2 Global Abrocitinib API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Abrocitinib API Sale Price by Application (2018-2023)
3 Global Abrocitinib API by Company
3.1 Global Abrocitinib API Breakdown Data by Company
3.1.1 Global Abrocitinib API Annual Sales by Company (2018-2023)
3.1.2 Global Abrocitinib API Sales Market Share by Company (2018-2023)
3.2 Global Abrocitinib API Annual Revenue by Company (2018-2023)
3.2.1 Global Abrocitinib API Revenue by Company (2018-2023)
3.2.2 Global Abrocitinib API Revenue Market Share by Company (2018-2023)
3.3 Global Abrocitinib API Sale Price by Company
3.4 Key Manufacturers Abrocitinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Abrocitinib API Product Location Distribution
3.4.2 Players Abrocitinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Abrocitinib API by Geographic Region
4.1 World Historic Abrocitinib API Market Size by Geographic Region (2018-2023)
4.1.1 Global Abrocitinib API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Abrocitinib API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Abrocitinib API Market Size by Country/Region (2018-2023)
4.2.1 Global Abrocitinib API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Abrocitinib API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Abrocitinib API Sales Growth
4.4 APAC Abrocitinib API Sales Growth
4.5 Europe Abrocitinib API Sales Growth
4.6 Middle East & Africa Abrocitinib API Sales Growth
5 Americas
5.1 Americas Abrocitinib API Sales by Country
5.1.1 Americas Abrocitinib API Sales by Country (2018-2023)
5.1.2 Americas Abrocitinib API Revenue by Country (2018-2023)
5.2 Americas Abrocitinib API Sales by Type
5.3 Americas Abrocitinib API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Abrocitinib API Sales by Region
6.1.1 APAC Abrocitinib API Sales by Region (2018-2023)
6.1.2 APAC Abrocitinib API Revenue by Region (2018-2023)
6.2 APAC Abrocitinib API Sales by Type
6.3 APAC Abrocitinib API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Abrocitinib API by Country
7.1.1 Europe Abrocitinib API Sales by Country (2018-2023)
7.1.2 Europe Abrocitinib API Revenue by Country (2018-2023)
7.2 Europe Abrocitinib API Sales by Type
7.3 Europe Abrocitinib API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Abrocitinib API by Country
8.1.1 Middle East & Africa Abrocitinib API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Abrocitinib API Revenue by Country (2018-2023)
8.2 Middle East & Africa Abrocitinib API Sales by Type
8.3 Middle East & Africa Abrocitinib API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Abrocitinib API
10.3 Manufacturing Process Analysis of Abrocitinib API
10.4 Industry Chain Structure of Abrocitinib API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Abrocitinib API Distributors
11.3 Abrocitinib API Customer
12 World Forecast Review for Abrocitinib API by Geographic Region
12.1 Global Abrocitinib API Market Size Forecast by Region
12.1.1 Global Abrocitinib API Forecast by Region (2024-2029)
12.1.2 Global Abrocitinib API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Abrocitinib API Forecast by Type
12.7 Global Abrocitinib API Forecast by Application
13 Key Players Analysis
13.1 Toronto Research Chemicals
13.1.1 Toronto Research Chemicals Company Information
13.1.2 Toronto Research Chemicals Abrocitinib API Product Portfolios and Specifications
13.1.3 Toronto Research Chemicals Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Toronto Research Chemicals Main Business Overview
13.1.5 Toronto Research Chemicals Latest Developments
13.2 AbMole BioScience
13.2.1 AbMole BioScience Company Information
13.2.2 AbMole BioScience Abrocitinib API Product Portfolios and Specifications
13.2.3 AbMole BioScience Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AbMole BioScience Main Business Overview
13.2.5 AbMole BioScience Latest Developments
13.3 TargetMol Chemicals
13.3.1 TargetMol Chemicals Company Information
13.3.2 TargetMol Chemicals Abrocitinib API Product Portfolios and Specifications
13.3.3 TargetMol Chemicals Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TargetMol Chemicals Main Business Overview
13.3.5 TargetMol Chemicals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Abrocitinib API Product Portfolios and Specifications
13.4.3 Pfizer Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 CSNpharm
13.5.1 CSNpharm Company Information
13.5.2 CSNpharm Abrocitinib API Product Portfolios and Specifications
13.5.3 CSNpharm Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CSNpharm Main Business Overview
13.5.5 CSNpharm Latest Developments
13.6 Abcam
13.6.1 Abcam Company Information
13.6.2 Abcam Abrocitinib API Product Portfolios and Specifications
13.6.3 Abcam Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abcam Main Business Overview
13.6.5 Abcam Latest Developments
13.7 Cayman Chemical
13.7.1 Cayman Chemical Company Information
13.7.2 Cayman Chemical Abrocitinib API Product Portfolios and Specifications
13.7.3 Cayman Chemical Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cayman Chemical Main Business Overview
13.7.5 Cayman Chemical Latest Developments
13.8 MedKoo Biosciences
13.8.1 MedKoo Biosciences Company Information
13.8.2 MedKoo Biosciences Abrocitinib API Product Portfolios and Specifications
13.8.3 MedKoo Biosciences Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MedKoo Biosciences Main Business Overview
13.8.5 MedKoo Biosciences Latest Developments
13.9 Clearsynth
13.9.1 Clearsynth Company Information
13.9.2 Clearsynth Abrocitinib API Product Portfolios and Specifications
13.9.3 Clearsynth Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Clearsynth Main Business Overview
13.9.5 Clearsynth Latest Developments
13.10 Changzhou Pharmaceutical Factory
13.10.1 Changzhou Pharmaceutical Factory Company Information
13.10.2 Changzhou Pharmaceutical Factory Abrocitinib API Product Portfolios and Specifications
13.10.3 Changzhou Pharmaceutical Factory Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Changzhou Pharmaceutical Factory Main Business Overview
13.10.5 Changzhou Pharmaceutical Factory Latest Developments
13.11 ComWin Internationa
13.11.1 ComWin Internationa Company Information
13.11.2 ComWin Internationa Abrocitinib API Product Portfolios and Specifications
13.11.3 ComWin Internationa Abrocitinib API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 ComWin Internationa Main Business Overview
13.11.5 ComWin Internationa Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Abrocitinib API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Abrocitinib API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Abrocitinib API Sales by Type (2018-2023) & (Tons)
Table 6. Global Abrocitinib API Sales Market Share by Type (2018-2023)
Table 7. Global Abrocitinib API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Abrocitinib API Revenue Market Share by Type (2018-2023)
Table 9. Global Abrocitinib API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Abrocitinib API Sales by Application (2018-2023) & (Tons)
Table 11. Global Abrocitinib API Sales Market Share by Application (2018-2023)
Table 12. Global Abrocitinib API Revenue by Application (2018-2023)
Table 13. Global Abrocitinib API Revenue Market Share by Application (2018-2023)
Table 14. Global Abrocitinib API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Abrocitinib API Sales by Company (2018-2023) & (Tons)
Table 16. Global Abrocitinib API Sales Market Share by Company (2018-2023)
Table 17. Global Abrocitinib API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Abrocitinib API Revenue Market Share by Company (2018-2023)
Table 19. Global Abrocitinib API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Abrocitinib API Producing Area Distribution and Sales Area
Table 21. Players Abrocitinib API Products Offered
Table 22. Abrocitinib API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Abrocitinib API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Abrocitinib API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Abrocitinib API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Abrocitinib API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Abrocitinib API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Abrocitinib API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Abrocitinib API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Abrocitinib API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Abrocitinib API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Abrocitinib API Sales Market Share by Country (2018-2023)
Table 35. Americas Abrocitinib API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Abrocitinib API Revenue Market Share by Country (2018-2023)
Table 37. Americas Abrocitinib API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Abrocitinib API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Abrocitinib API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Abrocitinib API Sales Market Share by Region (2018-2023)
Table 41. APAC Abrocitinib API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Abrocitinib API Revenue Market Share by Region (2018-2023)
Table 43. APAC Abrocitinib API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Abrocitinib API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Abrocitinib API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Abrocitinib API Sales Market Share by Country (2018-2023)
Table 47. Europe Abrocitinib API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Abrocitinib API Revenue Market Share by Country (2018-2023)
Table 49. Europe Abrocitinib API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Abrocitinib API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Abrocitinib API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Abrocitinib API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Abrocitinib API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Abrocitinib API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Abrocitinib API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Abrocitinib API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Abrocitinib API
Table 58. Key Market Challenges & Risks of Abrocitinib API
Table 59. Key Industry Trends of Abrocitinib API
Table 60. Abrocitinib API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Abrocitinib API Distributors List
Table 63. Abrocitinib API Customer List
Table 64. Global Abrocitinib API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Abrocitinib API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Abrocitinib API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Abrocitinib API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Abrocitinib API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Abrocitinib API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Abrocitinib API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Abrocitinib API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Abrocitinib API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Abrocitinib API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Abrocitinib API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Abrocitinib API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Abrocitinib API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Abrocitinib API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Toronto Research Chemicals Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 79. Toronto Research Chemicals Abrocitinib API Product Portfolios and Specifications
Table 80. Toronto Research Chemicals Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Toronto Research Chemicals Main Business
Table 82. Toronto Research Chemicals Latest Developments
Table 83. AbMole BioScience Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 84. AbMole BioScience Abrocitinib API Product Portfolios and Specifications
Table 85. AbMole BioScience Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. AbMole BioScience Main Business
Table 87. AbMole BioScience Latest Developments
Table 88. TargetMol Chemicals Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 89. TargetMol Chemicals Abrocitinib API Product Portfolios and Specifications
Table 90. TargetMol Chemicals Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. TargetMol Chemicals Main Business
Table 92. TargetMol Chemicals Latest Developments
Table 93. Pfizer Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Abrocitinib API Product Portfolios and Specifications
Table 95. Pfizer Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. CSNpharm Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 99. CSNpharm Abrocitinib API Product Portfolios and Specifications
Table 100. CSNpharm Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. CSNpharm Main Business
Table 102. CSNpharm Latest Developments
Table 103. Abcam Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 104. Abcam Abrocitinib API Product Portfolios and Specifications
Table 105. Abcam Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Abcam Main Business
Table 107. Abcam Latest Developments
Table 108. Cayman Chemical Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 109. Cayman Chemical Abrocitinib API Product Portfolios and Specifications
Table 110. Cayman Chemical Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Cayman Chemical Main Business
Table 112. Cayman Chemical Latest Developments
Table 113. MedKoo Biosciences Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 114. MedKoo Biosciences Abrocitinib API Product Portfolios and Specifications
Table 115. MedKoo Biosciences Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. MedKoo Biosciences Main Business
Table 117. MedKoo Biosciences Latest Developments
Table 118. Clearsynth Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 119. Clearsynth Abrocitinib API Product Portfolios and Specifications
Table 120. Clearsynth Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Clearsynth Main Business
Table 122. Clearsynth Latest Developments
Table 123. Changzhou Pharmaceutical Factory Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 124. Changzhou Pharmaceutical Factory Abrocitinib API Product Portfolios and Specifications
Table 125. Changzhou Pharmaceutical Factory Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Changzhou Pharmaceutical Factory Main Business
Table 127. Changzhou Pharmaceutical Factory Latest Developments
Table 128. ComWin Internationa Basic Information, Abrocitinib API Manufacturing Base, Sales Area and Its Competitors
Table 129. ComWin Internationa Abrocitinib API Product Portfolios and Specifications
Table 130. ComWin Internationa Abrocitinib API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. ComWin Internationa Main Business
Table 132. ComWin Internationa Latest Developments
List of Figures
Figure 1. Picture of Abrocitinib API
Figure 2. Abrocitinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Abrocitinib API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Abrocitinib API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Abrocitinib API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Abrocitinib API Sales Market Share by Type in 2022
Figure 12. Global Abrocitinib API Revenue Market Share by Type (2018-2023)
Figure 13. Abrocitinib API Consumed in Research Institute
Figure 14. Global Abrocitinib API Market: Research Institute (2018-2023) & (Tons)
Figure 15. Abrocitinib API Consumed in Pharmaceutical
Figure 16. Global Abrocitinib API Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. Abrocitinib API Consumed in Others
Figure 18. Global Abrocitinib API Market: Others (2018-2023) & (Tons)
Figure 19. Global Abrocitinib API Sales Market Share by Application (2022)
Figure 20. Global Abrocitinib API Revenue Market Share by Application in 2022
Figure 21. Abrocitinib API Sales Market by Company in 2022 (Tons)
Figure 22. Global Abrocitinib API Sales Market Share by Company in 2022
Figure 23. Abrocitinib API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Abrocitinib API Revenue Market Share by Company in 2022
Figure 25. Global Abrocitinib API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Abrocitinib API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Abrocitinib API Sales 2018-2023 (Tons)
Figure 28. Americas Abrocitinib API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Abrocitinib API Sales 2018-2023 (Tons)
Figure 30. APAC Abrocitinib API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Abrocitinib API Sales 2018-2023 (Tons)
Figure 32. Europe Abrocitinib API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Abrocitinib API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Abrocitinib API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Abrocitinib API Sales Market Share by Country in 2022
Figure 36. Americas Abrocitinib API Revenue Market Share by Country in 2022
Figure 37. Americas Abrocitinib API Sales Market Share by Type (2018-2023)
Figure 38. Americas Abrocitinib API Sales Market Share by Application (2018-2023)
Figure 39. United States Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Abrocitinib API Sales Market Share by Region in 2022
Figure 44. APAC Abrocitinib API Revenue Market Share by Regions in 2022
Figure 45. APAC Abrocitinib API Sales Market Share by Type (2018-2023)
Figure 46. APAC Abrocitinib API Sales Market Share by Application (2018-2023)
Figure 47. China Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Abrocitinib API Sales Market Share by Country in 2022
Figure 55. Europe Abrocitinib API Revenue Market Share by Country in 2022
Figure 56. Europe Abrocitinib API Sales Market Share by Type (2018-2023)
Figure 57. Europe Abrocitinib API Sales Market Share by Application (2018-2023)
Figure 58. Germany Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Abrocitinib API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Abrocitinib API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Abrocitinib API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Abrocitinib API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Abrocitinib API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Abrocitinib API in 2022
Figure 73. Manufacturing Process Analysis of Abrocitinib API
Figure 74. Industry Chain Structure of Abrocitinib API
Figure 75. Channels of Distribution
Figure 76. Global Abrocitinib API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Abrocitinib API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Abrocitinib API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Abrocitinib API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Abrocitinib API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Abrocitinib API Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアブロシチニブAPI市場予測 2023年-2029年(Global Abrocitinib API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のアブロシチニブAPI市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp